Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

French study tracks port wine stains in kids to uncover hidden risks

NCT ID NCT01364857

Knowledge-focused Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 150 children aged 2 to 12 who have a port wine stain on a leg. Researchers tracked how the stain changes as the child grows, and whether it leads to problems like blood vessel issues or bone growth differences. The goal was to learn more about the condition and find clues that could help predict complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Nov 2010

Finished

Nov 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child between 2 and 12 years old with a port wine stain on a lower limb ( or two lower limbs) with national health assurance with consent from one parent Exclusion Criteria: * child with orthopedic impairment with no link with the port wine stain

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Klippel-Trenaunay syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

angioosteohypertrophic syndrome familial multiple nevi flammei Parkes Weber syndrome Port-Wine Stain Sturge-Weber syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Klippel-Trenaunay syndrome Parkes weber syndrome Port-wine stain

Contacts and locations

Locations

  • Service de Dermatologie, Bâtiment tardieu

    Le Mans, 72037, France

  • Service de Dermatologie, Hôpital Pontchaillou, CHU de Rennes

    Rennes, 35033, France

  • Service de Dermatologie, Hôpital St Eloi

    Montpellier, 34295, France

  • Service de dermatlogie

    Quimper, 29107, France

  • Service de dermatologie

    Amiens, 80054, France

  • Service de dermatologie

    Angers, 49933, France

  • Service de dermatologie

    Bordeaux, 33000, France

  • Service de dermatologie

    Caen, 14033, France

  • Service de dermatologie

    Dijon, 21079, France

  • Service de dermatologie

    Nantes, 44093, France

  • Service de dermatologie

    Nice, 06202, France

  • Service de dermatologie

    Paris, 75743, France

  • Service de dermatologie

    Reims, 51092, France

  • Service de dermatologie

    Rouen, 76031, France

  • Service de dermatologie

    Saint-Etienne, 42055, France

  • Service de dermatologie

    Toulouse, 31059, France

  • Service de dermatologie

    Tours, 37044, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.